Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

Zoetis' strategic divestiture of non-core assets and strong market position in companion animal drugs support a robust growth ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

attachment. Solensia (frunevetmab injection) is a monoclonal antibody drug used for the control of pain associated with ...

The following is a summary of “Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data from ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee. GNSC-001 is an investigational, adeno-associated virus gene ...